Correlation Between Alphabet and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alphabet and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class A CEDEAR and Pfizer Inc, you can compare the effects of market volatilities on Alphabet and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Pfizer.

Diversification Opportunities for Alphabet and Pfizer

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Alphabet and Pfizer is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class A CEDEAR and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class A CEDEAR are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Alphabet i.e., Alphabet and Pfizer go up and down completely randomly.

Pair Corralation between Alphabet and Pfizer

Assuming the 90 days trading horizon Alphabet Inc Class A CEDEAR is expected to generate 0.93 times more return on investment than Pfizer. However, Alphabet Inc Class A CEDEAR is 1.07 times less risky than Pfizer. It trades about -0.17 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.29 per unit of risk. If you would invest  346,500  in Alphabet Inc Class A CEDEAR on September 2, 2024 and sell it today you would lose (23,500) from holding Alphabet Inc Class A CEDEAR or give up 6.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alphabet Inc Class A CEDEAR  vs.  Pfizer Inc

 Performance 
       Timeline  
Alphabet Class A 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alphabet Inc Class A CEDEAR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Alphabet and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alphabet and Pfizer

The main advantage of trading using opposite Alphabet and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Alphabet Inc Class A CEDEAR and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments